COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 2717: Articles 27161-27170  | Next

Endotoxemia and circulating bacteriome in severe COVID-19 patients
Sirivongrangson, P., Kulvichit, W., Payungporn, S., Pisitkun, T., Chindamporn, A., Peerapornratana, S., Pisitkun, P., Chitcharoen, S., Sawaswong, V., Worasilchai, N., Kampunya, S., Putcharoen, O., Tawitsri, T., Leelayuwatanakul, N., Kongpolprom, N., Phoophiboon, V., Sriprasart, T., Samransamruajkit, R., Tungsanga, S., Tiankanon, K., Lumlertgul, N., Leelahavanichkul, A., Sriphojanart, T., Tantawichien, T., Thisyakorn, U., Chirathaworn, C., Praditpornsilpa, K., Tungsanga, K., Eiam-Ong, S., Sitprija, V., Kellum, J. A., Srisawat, N.
10.1101/2020.05.29.20109785 — Posted: 2020-06-02 Discussion: Offsite
POOLING FOR SARS-CoV-2 CONTROL IN CARE INSTITUTIONS
Cabrera, J. J., Rey, S., Perez, S., Martinez-Lamas, L., Cores-Calvo, O., Torres, J., Porteiro, J., Garcia-Comesana, J., Regueiro, B. J.
10.1101/2020.05.30.20108597 — Posted: 2020-06-02
Potential impact of Covid-19 response measures on invasive pneumococcal disease in England and Wales
Choi, Y. H., Miller, E.
10.1101/2020.06.01.20119057 — Posted: 2020-06-02
Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: prospective and retrospective applications
Buonanno, G., Morawska, L., Stabile, L.
10.1101/2020.06.01.20118984 — Posted: 2020-06-02 Discussion: Onsite
CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients
Dominguez Horta, M. d. C.
10.1101/2020.05.27.20110601 — Posted: 2020-06-02
The prevalence of antibodies to SARS-CoV-2 in asymptomatic healthcare workers with intensive exposure to COVID-19
Xiong, S., Guo, C., Dittmer, U., Zheng, X., Wang, B.
10.1101/2020.05.28.20110767 — Posted: 2020-06-02
Antibody profiling of COVID-19 patients in an urban low-incidence region in Northern Germany
Solbach, W., Schiffner, J., Backhaus, I., Burger, D., Staiger, R., Tiemer, B., Bobrowski, A., Hutchings, T., Mischnik, A.
10.1101/2020.05.30.20111393 — Posted: 2020-06-02
A cohort study to evaluate the effect of combination Vitamin D, Magnesium and Vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients.
Tan, C. W., Ho, L. P., Kalimuddin, S., Cherng, B. P. Z., Teh, Y. E., Thien, S. Y., Wong, H. M., Tern, P. J. W., Chay, J. W. M., Low, J. G. H., Ng, H. J.
10.1101/2020.06.01.20112334 — Posted: 2020-06-02 Discussion: Onsite
COVID-19: Why SOLIDARITY and DisCoVeRy trials may fail to bring informative and timely results
TOUMI, M., LIANG, S., DABBOUS, M., WANG, Y., QIU, T., HAN, R.
10.1101/2020.06.01.20118927 — Posted: 2020-06-02
Mathematical Modeling and Analysis of COVID-19 pandemic in Nigeria
Iboi, E. A., Sharomi, O. O., Ngonghala, C. N., Gumel, A. B.
10.1101/2020.05.22.20110387 — Posted: 2020-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).